Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
419 articles
Major study shows tirzepatide reduces cardiovascular and kidney complications by 16% compared to dulaglutide in diabetic patients.
Neurofilament light chain levels in blood strongly predict cardiovascular events and death in people with atrial fibrillation over 8 years.
Post-analysis of major trial shows extended apixaban treatment may prevent superficial vein thrombosis in patients with ongoing clotting risks.
Women who experience spontaneous coronary artery dissection during pregnancy face worse heart damage and slower recovery than non-pregnant cases.
New study uses cutting-edge imaging to solve the mystery of heart attacks that occur despite normal-looking coronary arteries.
Sotatercept emerges as potential treatment for combined pre-capillary pulmonary hypertension and heart failure with preserved ejection fraction.
Sotatercept reduced dangerous pressure in heart failure patients' lungs and improved walking ability in phase 2 study.
New research reveals how elevated Lp(a) levels interact with hormonal changes to significantly increase venous thromboembolism risk.
Large UK study reveals elevated Lp(a) levels raise venous thromboembolism risk by 32% in premenopausal women but not in men or postmenopausal women.
Large UK study shows exercise intensity matters more than total volume for preventing cardiovascular disease, diabetes, and dementia.
New study shows aggressive cholesterol-lowering therapy can halt progression of unstable arterial plaques that trigger heart attacks.
Major cholesterol-lowering drug alirocumab didn't reduce artery plaque buildup in heart transplant patients, despite cutting LDL by 57%.
